Related by context. All words. (Click for frequent words.) 83 EPS 79 diluted EPS 78 GAAP EPS 75 pro forma EPS 74 Adjusted EPS 74 Non GAAP EPS 70 FY# EPS 69 normalized EPS 69 2Q EPS 67 FY# EPS guidance 66 FY# revs 66 EPADS 66 Q1 EPS 66 EPS estimate 66 proforma EPS 65 adjusted EBITDA 65 normalized FFO 65 earnings 65 adj EPS 65 Q3 EPS 64 Sees FY# EPS 64 #Q# EPS 64 Q2 EPS 64 Pro forma EPS 64 F#Q# EPS 64 FY# EPS estimate 63 #.#-#.# usd [002] 63 Q4 EPS 63 excluding nonrecurring items 63 Adjusted Diluted EPS 63 Q# revs 63 EBITDA 63 FQ2 EPS 63 FQ1 EPS 62 FFO 62 #E EPS 62 adjusted EBIT 62 FQ4 EPS 62 adjusted Ebitda 62 F4Q 62 Diluted EPS 62 non GAAP 61 pro forma 61 Pro Forma EPS 61 FQ3 EPS 61 EPS Guidance 61 Q4 revs 61 sees FY# EPS 61 Normalized EPS 61 EBIT 61 Q3 revs 60 pro forma adjusted EBITDA 60 F2Q 60 EBITA 60 Quick Facts2 60 Raises FY# EPS 60 Earnings Per Share 60 Sees Q4 60 netincome 60 Zacks Consensus Estimates 60 EPS accretion 59 Q4 adj EPS 59 Q2 adj 59 REBIT 59 CY# EPS 59 Reaffirms FY# EPS 59 Fully diluted EPS 59 F1Q EPS 59 Q1 revs 59 Q2 revs 59 #.#-#.# excluding 59 Zacks Consensus 59 '#E EPS 59 FQ1 59 FY# adj 59 F1Q 59 F3Q 59 nonGAAP 59 EBITA margin 58 lowers FY# EPS 58 FQ3 58 EPS ests 58 earnigns 58 #.#-#.# bln [007] 58 F#Q# revenues 58 Lifts FY# EPS 58 Adjusted Earnings 58 Backs FY# EPS 58 Earnings 58 Sees Q3 58 #.# perdiluted 58 GBP#.#M [002] 58 Cuts FY# EPS 58 #.#/shr [002] 57 pro forma EBITDA 57 earnings pershare 57 Raises FY# 57 Earnings Guidance 57 Reaffirms FY# 57 Guides Q3 57 Provides FY# EPS 57 Maintains FY# 57 ests 57 Q1 adj 57 Revises FY# EPS 57 excluding nonrecurring 57 #.#-#.# bln eur [003] 57 Reaffirms Full 57 FY# Guidance 57 #.#-#.# vs 57 Zacks Estimate 57 Consolidated Adjusted EBITDA 57 fiscal# 57 EDITDA 57 Sees FY# 56 FFO Per Share 56 OIBDA 56 Zacks Consensus Estimate 56 reaffirms FY# revs 56 Sees Q2 56 Q4 Adj 56 Reiterates FY# EPS 56 F2Q EPS 56 EBITDA margin 56 modestly accretive 56 Guides Q1 56 FQ2 56 Fully diluted earnings 56 EBIT margin 56 normalized EBITDA 56 FY# NPAT 56 fullyear 56 #.#/diluted share 56 DEPS 56 Q1 FY# EPS 56 CY# EPS estimate 56 adjusted1 56 Affirms FY# 56 Guides Q4 56 diluted share 56 EPS Excl 56 consensus estimate 56 Adjusted EBITDA 56 Sees FY 56 #,# c [002] 56 GAAP Diluted EPS 56 .#/share 56 Diluted earnings 56 Free Cash Flow 56 Lowers FY# EPS 56 FY# EPS Outlook 56 Lifts FY# Revenue 56 Backs FY# 55 modestly dilutive 55 excluding exceptionals 55 #.#-#.# mln usd 55 3Q earns 55 pershare 55 operating income1 55 CHF#.#B 55 #.#-#.# mln vs. [002] 55 F#Q# EPS ahead 55 reaffirms FY# 55 #.#/sh 55 pro forma basis 55 Sees Q1 55 Net Income 55 GBP#.#M [003] 55 Below Consensus 55 Updates FY# EPS 55 Carrols Restaurant 55 gross margin 55 F#Q# 55 heps 55 Reiterates Guidance 55 items affecting comparability 55 SEK#M 55 #QF# 55 Boosts FY# 55 Q4 55 Guides FY# EPS 55 Sees FY# adj EPS 55 Normalised earnings 55 consolidated OIBDA 55 amortization OIBDA 55 View Quick Facts 55 Backs FY# Revenue 55 FY# FY# EPS 55 FFOPS 55 Non GAAP Adjusted EBITDA 55 Loss Per Share 55 FQ4 55 EPS Rises 55 #.#-#.# mln [001] 55 Projected FFO 54 Non GAAP diluted 54 Oibda 54 Guides Q2 54 non gaap 54 #.#-#.# bln eur [005] 54 EBTIDA 54 Co reaffirms FY# 54 Sees FY# revs 54 Oxy ER 54 pretax profit 54 FFO FFO 54 Sees Q# 54 #.#-#.# bln usd [004] 54 Matches Estimate 54 ROCE 54 pre exceptionals 54 Normalized EBITDA 54 #.#-# mln [001] 54 EPADR 54 F3Q EPS 54 Ebitda 54 per MCFE 54 Backs FY# Adj 54 adj Q4 54 EBIDTA 54 FY# Quick Facts 54 Forecast Quick Facts 54 F#Q# Earnings 54 #-#.# mln [002] 54 F4Q EPS 54 Normalised headline 54 Adjusted diluted 54 Q3 adj 54 Misses Consensus 54 Pro forma Adjusted EBITDA 54 items impacting comparability 54 #.#-#.# bln dkr [002] 54 NPAT 54 adjusted OIBDA 54 continuingoperations 54 Adjusted EBIT 54 Exceptional Items 54 Non GAAP adjusted EBITDA 54 GAAP 54 adjusted EBITDAR 54 FY# [001] 54 Q1 54 Q4 adj 54 2nd qtr profit 53 Lowers FY# 53 #.#-#.# mln [004] 53 Operational EBITDA 53 EBITD 53 Remains Inline 53 ROIC 53 Q4 FY# EPS 53 Cuts FY# 53 diluted HEPS 53 Including discontinued operations 53 operatingincome 53 Q3 53 Q2 53 Q1 Adj 53 EUR#M EUR#M 53 profit beia 53 non recurring 53 #.#-#.# bln [002] 53 adjusted1 net 53 EBITDAO 53 Backs FY# Earnings 53 revises FY# 53 Lifts FY# Earnings 53 Q2 Profit 53 CHF#.# billion [002] 53 EBITDAA 53 per share1 53 Lifts FY# Outlook 53 Lifts Quarterly Dividend 53 CFFO 53 pretax profits 53 Tops Consensus 53 Above Consensus 53 GBP#.#B [001] 53 CHF#M 53 Reaffirms Outlook 53 Boosts FY# EPS 53 USD #.#bln [001] 53 Adjusted Pro Forma 53 Pepsi Bottling PBG 53 fully diluted 53 '#E 53 Fully Diluted EPS 53 1/share 53 AFFO 53 Ebit margin 53 Adjusted Basis 53 LABL 53 Luminex NASDAQ LMNX 53 #.#-#.# mln vs. [001] 53 Reiterates FY# 53 #.#-#.# bln eur [002] 53 Misses View 53 Vishay Intertechnology VSH 53 #.#x FY#E [002] 53 SmartEstimate 53 Reuters Estimates 52 1st qtr profit 52 Slashes FY# 52 opg margin 52 EPADS estimate 52 NASDAQ PRXL 52 Q#/FY# 52 Pro forma diluted 52 Tops Estimate 52 reports Q4 adj 52 Full Year 52 NASDAQ XRAY 52 diluted EPADS 52 Littelfuse NASDAQ LFUS 52 FY#Q# 52 #-# MMcfe d 52 Reaffirms Guidance 52 Exceeds Guidance 52 Recurring FFO 52 proforma 52 Q3 Profit Slips 52 #.#/share [002] 52 Ps.#.# [006] 52 Guidance Quick Facts 52 ESTIMATE FOR 52 SEK#.#B 52 #e EPS 52 invoiced shipments 52 #-# mln sfr 52 nonoperating items 52 Q2 Adj 52 FY# Adj 52 Guides FY# 52 SEK#.#bn [002] 52 Tightens FY# 52 3rd qtr profit 52 Narrows Guidance 52 Guides Below 52 COMPANY SYMBOL QTR EPS 52 Earnings Preview Bristol Myers 52 distributable earnings 52 FNDT 52 sees FY# revs 52 opg profit 52 cont ops 52 3Q 52 Revises FY# 52 EBITDA1 52 Lowers Guidance 52 oper profit 52 AMSG 52 pretax 52 underlying NPAT 52 Guides Inline 52 EPADS estimates 52 Ebita 52 4Q 52 Below Estimates 52 sees FY opg 52 Guides Q# 52 Items Affecting Comparability 52 Earning Per Share 52 Valspar VAL 52 reiterates FY 52 ebita 52 goodwill amortization 52 mainline CASM 51 Lifts FY# 51 #x #E 51 #-#.# mln eur 51 Outlook Disappoints 51 Q3 Adj 51 Q2 F# 51 #.#-#.# bln eur [004] 51 Diluted EPS Guidance 51 BVPS 51 FY opg 51 ULGX 51 diluted FAD 51 Beats Estimate Update 51 Individual Annuities segment 51 Inc. Nasdaq AEPI 51 qtly profit 51 Tops Estimates Update 51 Raises Guidance 51 WW Grainger GWW 51 HEPS 51 Ebita margin 51 posts 4th qtr 51 excluding goodwill impairment 51 DAC unlock 51 per dilutedshare 51 Ups Guidance 51 Adjusted Earnings Per 51 Reaffirms FY# Earnings 51 Q1 FY# [002] 51 Pro forma EBITDA 51 Realized Earnings 51 Beats Consensus 51 adjusted2 51 reaffirms FY# guidance 51 Recurring EBITDA 51 Beats Estimate 51 analystsâ 51 Adjusted OIBDA 51 reports Q3 adj 51 CY#E EPS 51 aftertax gain 51 adjusted EBITA 51 F#H# 51 DKK#.# [001] 51 PDP MLR 51 #.# bln dkr [002] 51 HB Fuller NYSE FUL 51 Q4 FY# [002] 51 DEPS guidance 51 reaffirms FY# EPS 51 GAAP Generally Accepted 51 Q4 Profit Soars 51 Q2 opg 51 Steiner Leisure NASDAQ STNR 51 Diluted Share 51 adjusted HEPS 51 FY#E EPS [002] 51 Core FFO 51 #x FY#E EPS [001] 51 Non IFRS 51 Reaffirms Fiscal 51 Guidance Raised 51 Narrows Quick Facts 51 EBTA 51 normalized EBIT 51 Raises PT 51 H1 FY# [001] 51 Misses Q3 51 netsales 51 FY# EPS View 51 Brush Engineered 51 opg 51 Revises FY# Outlook 51 Ebitda margin 51 Operating Cash Flow 51 Outlook Quick Facts 51 Realised Earnings 51 Profit Rises Quick Facts 51 nonrecurring items 51 Q2 FY# [001] 51 ebitda 51 EBITANCE 51 Acergy ACGY 51 EUR#.#B [003] 51 Profit Grows 51 earns rev 51 Q3 Profit Surges 51 1H FY# [002] 51 Selected GAAP Measures 51 Fiscal 1Q Profit 51 Q4 Profit Climbs 51 Meets Estimates 50 LIFO adjustment 50 Adjusted EBITA 50 FFO Declines 50 CFNB 50 Fiscal Quarter Earnings 50 adjusted ebitda 50 Tops Estimate Update 50 Pro Forma EBITDA 50 amortization EBITDA 50 EPS accretive 50 OCF margin 50 qtly 50 EBDITA 50 CGNX 50 Outperform recommendation 50 DiaMed acquisition 50 Misses Views 50 Fourth Quarter Results 50 Adjusted FIFO EBITDA 50 ROACE 50 Earnings Preview EBay 50 ay y basis 50 Quarter Fiscal 50 exceptionals 50 Fy# 50 #.#/ADR 50 ATCF 50 #.# bln sfr [002] 50 Urban Outfitters NASDAQ URBN 50 Chemed Corporation 50 3Q 4Q 50 Sees 3Q 50 4th Quarter Earnings 50 posts 2nd qtr 50 FY#e 50 Misses Q2 50 Omrix Biopharma 50 Fourth Quarter Earnings Per 50 Constant Currency 50 DKK#.# [003] 50 FY #E [001] 50 #.#-#.# bln usd [002] 50 Q3 Profit Climbs 50 Unlevered Cash Flow 50 Beats Estimates Analyst Blog 50 Beats Zacks 50 EBITDAF 50 EBITDAC 50 Deckers Outdoor 50 NewsBite Downgrade Puts Pressure 50 Loss Reduces 50 Consensus Estimate 50 Non GAAP 50 adjusted OIBDA margin 50 #.#x FY# [002] 50 Canaccord Genuity Maintains Hold 50 FY#E EPS [001] 50 Q3 Profit 50 FY opg profit 50 Boosts Quarterly Dividend 50 Q4 Profit Jumps 50 EUR#.# EUR#.# [002] 50 Q1 F# 50 Reaffirms FY# Revenue 50 Cents Vs 50 Reaffirms Second Quarter 50 Excluding goodwill impairment 50 Q2 FY 50 nonroutine income 50 Wireline adjusted EBITDA 50 Pro forma FFO 50 HB Fuller FUL 50 #.#cps [002] 50 excluding divestments 50 Of #.#p Vs [002] 50 cents ashare 50 #cps 50 #Q# [002] 50 Loss Shrinks 50 #.#x FY# [003] 50 Ametek AME 50 Confirms Guidance 50 Volterra Semi 50 4Q Profit 50 Q3 Profit Plunges 50 SS NOI 50 Consolidated Adjusted OIBDA 50 proforma basis 50 CNMD 50 Varian Semi 50 Knology NASDAQ KNOL 50 #.#x #.#x [003] 50 1Q 50 Earnings Announcement Date 50 Projected FFO per 50 FY div 50 Fourth Quarter Earnings Preview 50 FFO payout ratio 50 PBDIT 50 thefourth quarter 50 capital employed ROACE 50 Consolidated EBITDA Margin 50 Revises Q4 50 Operating Income 50 Q2 Profit Soars 50 qtrly 50 CY#E [001] 50 Q2 Profit Jumps 50 Of #.#p Vs [004] 50 Declines Quick Facts 50 NuVasive NASDAQ NUVA 50 2Q 50 SEK#.# [002] 50 Y#.# prft Y#.# prft [002] 50 Lowers Q4 50 EBT amounted 50 5/share 50 TEUR -# 50 FIFO EBITDA 50 Neutral recommendation 50 Tops Views 50 Matches Consensus 49 NASDAQ MYL 49 Earnings Surge 49 Q1 Profit Declines 49 Narrows FY# EPS 49 Dress Barn NASDAQ DBRN 49 Postpay ARPU 49 FMER 49 Above Estimates 49 NASDAQ SLXP 49 Q4 Profit 49 DCF valuation 49 Misses Q4 49 Revises Guidance 49 NASDAQ TAST 49 1Q Earnings 49 Diluted HEPS 49 FY#E respectively 49 Beats Views 49 EBIDA 49 Normalized FFO 49 Sees 2Q Profit 49 #.#-#.# mln eur [001] 49 Ebit 49 PTOI 49 AmerisourceBergen ABC 49 Net Loss 49 payout ratio 49 3rd Quarter Earnings 49 +#-# [019] 49 Expects FY# 49 quarter# 49 Reports Narrower Loss 49 proforma revenues 49 Cymer NASDAQ CYMI 49 Adjusted FFO 49 PV module shipments 49 prioryear 49 Euro#.# [003] 49 Adjusted Ebitda 49 2Q Profit 49 ESCO Technologies 49 COGN 49 OPANA franchise 49 museum Julie Setlock 49 guides FY# EPS 49 From Cont 49 ay y decline 49 FFOM 49 Q1 Profit Dips 49 Rises Beats Estimates 49 gross margins 49 GBP #.#bln [001] 49 NYSE CEG ranks 49 SHLM 49 #.#-#.# vs. 49 Spreadtrum Comms 49 Misses Expectations 49 SCHEDULED TO PREMIERE 49 Pro forma 49 Q1 Profit Climbs 49 Q2 Profit Plunges 49 Waste Connections WCN 49 Signet Jewelers 49 Guidance Disappoints 49 Adjusted EBITDAS 49 4Q Profit Falls 49 Regeneron Pharma 49 Earnings Per Diluted 49 Q2 Profit Declines 49 posts 3rd qtr 49 PWOD 49 Changyou.com Limited NASDAQ CYOU 49 EBITDAS 49 adj Q3 49 Reaffirms Fourth Quarter 49 2/share 49 fy# 49 GBP#M [001] 49 Declares Dividend Update 49 ROFE 49 USD#.#m USD#.# per [001] 49 month TTM EPS 49 narrows 4Q loss 49 inactive premarket 49 Q4 Profit Slips 49 True Religion Apparel TRLG 49 Non GAAP Earnings Per 49 4th qtr profit 49 ESIO 49 3/share 49 3Q Earnings 49 Non GAAP Diluted EPS 49 Unfavourable Changes 49 Sirona Dental 49 Dicks Sporting Goods DKS 49 Reiterate Buy 49 Q1 Profit Surges 49 OIBA 49 Bebe Stores 49 Neutral Analyst Blog 49 SEK -#.# -#.# [001] 49 Ups Dividend 49 COHU 49 Fully Taxed EPS 49 #x FY# EPS 49 China Biotics NASDAQ CHBT 49 Q1 Profit Soars 49 SEK -#.# [001] 49 Lowers FY# Outlook 49 revenue USD #.#bln 49 Bioprocess Division 49 Pretax profits 49 NOK#.# [006] 49 EnPro consolidated 49 Profit Rises Update 49 Excluding nonrecurring items 49 Backs FY# Outlook 49 Normalized Earnings 49 aP S 49 q2 49 Increases Quarterly Dividend 49 BRE Properties BRE 49 Operational Results 49 Reaffirms Earnings 49 EBIDTA margins 49 Backs FY# Forecast 49 #c #c [002] 49 Of #.#p Vs [003] 49 Professional Instrumentation 49 adjusted Ebit 49 Q2 Profit Climbs 49 Susquehanna Bancshares NASDAQ SUSQ 49 PRXL 49 Guides Above 49 TTM EPS 49 vs #.#m bt 49 Operations FFO 49 Hanger Orthopedic 49 Molex NASDAQ MOLX 49 #.#ma [005] 49 3rd qtr 49 Ebidta 49 millioncompared 49 Medicare Advantage MLR 49 4Q Profit Down 49 accretive thereafter 49 amortization EBITA 49 Continuing Operations 49 NASDAQ GS IPAR 49 FY# FY# [001] 49 USD#.#m USD#.# per [002] 49 Pro Forma Adjusted EBITDA 49 Fiscal Quarter Results 49 BioDelivery Sciences NASDAQ BDSI 49 Hovnanian trims 49 Q2 Profit Surges 49 EPS GUIDANCE 49 Second Quarter Earnings Per 49 EARNINGS IN RETROSPECT 49 Upside Purchased 49 Q4 FY 49 Earnings Preview IAC 49 #.# bln dkr [001] 49 Hikes Dividend 49 4Q FY# 49 NYSE KDN 49 NASDAQ BECN 49 SSNOI 49 #,# TWh implying 49 Q4 Profit Plummets 49 AMAG Pharmaceuticals AMAG 49 aq q 49 eps 49 robust F#Q# 49 Qtr Qtr 49 Opns 49 underlying pretax 49 Trades -#.# 49 Rockwell Automation ROK 49 #.#-#.# bln [004] 49 EUR#.#B [004] 49 TEB adjustment 49 Market Outperform Rating 49 MedcoHealth 48 2Q Profit Rises 48 Pretax Profit 48 Adjusted Operating 48 #.#-#.# bln [005] 48 Conceptus Inc 48 #.#-#.# bln [001] 48 Prepaid ARPU 48 Revises FY# Guidance 48 Segment EBIT 48 Noninterest Expense Noninterest expense 48 Operating Profit 48 Q2 FY# [002] 48 Q1 Profit Drops 48 Diluted Earnings Per Share 48 3Q Profit Rises 48 #.#/Share [002] 48 NYSE GIL 48 FY Pretax Pft 48 YTD Q3 48 PharmaNet Development 48 Q3 Profit Jumps 48 Loss Narrowed 48 #.# bln usd [001] 48 Q2 Profit Decreases 48 MRTN 48 Lithia Motors LAD 48 Adjusted EBITDA1 48 SFr#.# billion [002] 48 StanCorp Financial 48 Tops Q4 48 Adjusted EBITDA Adjusted 48 GAAP Measures 48 Raises Outlook 48 Earnings Preview Activision Blizzard 48 UBS Maintains Neutral 48 Maintains Hold 48 ATOI 48 Thomson First 48 Biggest laggers 48 mildly dilutive 48 Irvine Sensors Releases 48 UACL 48 Trades +#.# % 48 H1 FY# [002] 48 THE OUTLOOK 48 Q4 Profit Surges 48 Guides FY# Quick Facts 48 Q4 Profit Rises 48 Reiterates Fiscal 48 Earnings Decline 48 Revenue Climbs 48 Revises Fiscal 48 Boosts Dividend 48 Acuity Brands AYI 48 adjusted EBITDAS 48 Corp. MCK 48 pct beats f'cast 48 Dionex NASDAQ DNEX 48 1H pretax 48 EBITDAX 48 Results Beats Estimates 48 NASDAQ TXRH 48 Vs Pft 48 EUR#.#M [002] 48 outlook disappoints 48 Amkor Technology NASDAQ AMKR 48 cash flow 48 Reports FY# EPS 48 Updates Fourth Quarter 48 revs Reports 48 Darden Restaurants DRI 48 #H# NPAT 48 QUALCOMM pro forma 48 GUIDANCE 48 FFIN 48 KNSY 48 Sees 4Q 48 MA PFFS 48 noncash pretax charge 48 Genuine Parts GPC 48 share.The 48 non GAAP1 48 Pro forma net 48 AFLAC AFL 48 DVFA SG 48 Q1 opg 48 Boosts Guidance 48 Raises Dividend 48 Immucor NASDAQ BLUD 48 Profit Forecast 48 Pro Forma Results 48 Equinix excludes 48 FactSet 48 #.#-#.# bln dkr [001] 48 NDSN 48 ended September# 48 NASDAQ BBBY 48 excludes nonrecurring items 48 Q3 Profit Declines 48 BUY rating 48 accretive 48 Hidden Gems recommendation 48 Consolidated EBITDAR 48 2nd Quarter Earnings 48 Rs#.#cr [003] 48 SYPR 48 Third Quarter Results 48 #.#per diluted 48 Fairly Valued stance 48 Qualcomm Strategic Initiatives 48 lifts FY# EPS 48 #.#p #.#p [007] 48 DKK#.# billion [002] 48 Align Technology NASDAQ ALGN 48 analystsâ € ™ 48 #.#x EV EBITDA [001] 48 DKK#.# [002] 48 beta coefficient 48 Q2 Profit Drops 48 AOCF 48 Waters WAT 48 #x #E EPS 48 typically exclude special 48 Otter Tail NASDAQ OTTR 48 Cytec Industries CYT 48 US#.#m [002] 48 normalized FFO guidance 48 #.#-#.# mln eur [002] 48 BGFV 48 NWY 48 SEK1 #m 48 Beats Raises Guidance 48 RDWR 48 NASDAQ MCRI 48 revises 4Q 48 Electro Scientific 48 mildly accretive 48 NASDAQ ISTA 48 Cubist Pharma 48 3Q Profit 48 HealthStream Learning 48 Boosts Qtr 48 Pall PLL 48 invoiced shipment 48 SMTL 48 noninterest expense totaled 48 QCRH 48 Hibbett Sports Inc 48 Rs #.#cr [006] 48 HDNG 48 Cont Ops 48 Kronos Worldwide 48 Its beta coefficient 48 Thomson FirstCall 48 A#.# #.#c 48 Deckers Outdoor NASDAQ DECK 48 EBIT beia 48 #x FY#E [002] 48 British Polythene 48 Revises Earnings 48 Bullish Technical Alert 48 Express Scripts NASDAQ ESRX 48 BioCryst Pharmaceuticals NASDAQ BCRX 48 Q4 F# 48 #.#x FY#E earnings [002] 48 DENTSPLY International 48 Profit Beats 48 minimally dilutive 48 Lowers 4Q 48 Margins Improve 48 IBKR 48 Earnings Scorecard 48 Q4 Profit Drops 48 LCRY 48 UPGRADED ONE WEEK AGO 48 #.#/share [006] 48 1Q Profit Triples 48 #.Net 48 Jefferies JEF 48 FY 48 Statutory Accounts 48 MARRIOTT REVENUES totaled 48 Overall NewMarket 48 Maxim Integrated Products MXIM 48 Gross Margin Gross 48 #QCY# [001] 48 Penwest Pharmaceuticals Co 48 AFFO payout ratio 48 Q4 Profit Decreases 48 Shire ADR Reptg 48 USD#.#m USD#.# [002] 48 Tibco TIBX 48 EUR -#.# [001] 48 Q2 Profit Rises 48 Q4 Profit Declines 48 Trubion Pharma 48 1Q Profit 48 PLN#.# billion [002] 48 Omnova Solutions NYSE OMN 48 US#.#bn [001] 48 noncash goodwill impairment 48 excluding reimbursables 48 Dover DOV 48 Kimberly Clark Corp 48 NASDAQ SMCI 48 Analyst Expectations 48 Electro Rent NASDAQ ELRC 48 Adjusted Net 48 Revises Third Quarter 48 #c #c [001] 48 Eastman Chemical NYSE EMN 48 VF Corp VFC 48 #.#x FY#E EPS [001] 48 CEDC discusses 48 n#.# [002] 48 TSEM 48 Q3 Profit Rises 48 Linear Technology LLTC 48 Distributable Income 48 Concur Technologies Inc CNQR 48 SEK -#.# [002] 48 Brands YUM 48 Saehan Bancorp Reports 48 #/shr 48 MNRO 48 Summarized consolidated 48 midsingle digit 48 thirteen analysts polled 48 DBRN 48 Eaton ETN 48 OIIM 48 ZUMZ 48 Yet Tops Estimate 48 Adjusted EBITDA Margin